Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPP Lavage in Knee Osteoarthritis
NCT03120988Phase 1Completed
- Sponsor
- Regenexx
- Start
- Jul 2016
- Primary completion
- Jun 2017
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of platelet-poor plasma in knee osteoarthritis (OA), sponsored by Regenexx. Primary endpoint: Mean temporal biomarkers at 4 weeks. Started Jul 2016; status: completed.
02
Drugs
platelet-poor plasma
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03120988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03120988.